CNO Financial Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CNO Financial Group, Inc. on October 3, 2017. The filing details the entry into a material definitive agreement regarding the company's poison pill defense mechanism, specifically the Third Amended and Restated Section 382 Rights Agreement.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder rights modifications rather than financial performance.
Material Changes
- Extension of Rights Plan: The company extended the expiration date of its Section 382 Rights Agreement from November 13, 2017, to November 13, 2020.
- Preferred Stock Series Update: The plan was amended to provide for a new series of preferred stock (Series D Junior Participating Preferred Stock) to replace the expiring Series C stock.
- Purchase Price Adjustment: The purchase price for the Rights was updated to $90.00 per one one-thousandth of a share of Series D Preferred Stock.
- Threshold Holder Definition: The agreement maintains a threshold of 4.99% beneficial ownership of Company 382 Securities to trigger the rights plan, unless approved by the Board.
Outlook, Risks, and Management Commentary
Purpose: The primary objective of the Amended Rights Agreement is to protect the Company's tax net operating loss (NOL) carryforwards from being jeopardized by a change in ownership under Section 382 of the Internal Revenue Code.
Shareholder Approval: The Company expects to submit the Amended Rights Agreement to stockholders for approval at the 2018 annual meeting. If approval is not received by October 3, 2018, or at the adjournment of the first annual meeting following the filing, the Rights will expire.
Redemption: The Board retains the right to redeem the Rights in whole at a price of $0.01 per Right at any time prior to the occurrence of a triggering event (an Acquiring Person becoming a Threshold Holder).
Triggering Events: If an Acquiring Person acquires 4.99% or more of the securities, Rights holders (excluding the Acquiring Person) may purchase shares of Common Stock or other securities with a market value of two times the Purchase Price.
Investor Verification Checklist
- Verify the status of the shareholder vote scheduled for the 2018 annual meeting regarding the Amended Rights Agreement.
- Confirm the specific terms of the Series D Junior Participating Preferred Stock as detailed in the Certificate of Designations (Exhibit 3.1).
- Monitor for any future filings regarding the redemption of the Rights or changes to the 4.99% ownership threshold.
- Review the full text of the Third Amended and Restated Section 382 Rights Agreement (Exhibit 4.1) for detailed definitions of "Exempted Person" and "Grandfathered Person."